BSE filing, NSE: LANCER. Summary written from the filing by ALFA Finder's alert engine.
Lancer Container Lines Ltd: key numbers
- Share price
- ₹10.05
- Market cap
- ₹355.0 Cr
- Revenue (annual)
- ₹394.0 Cr
- Net profit (annual)
- ₹5.63 Cr
- P/E (TTM)
- 22.9×Sector 28.1×
- Promoter holding
- 35.07%+3.40% QoQ
- FII holding
- 0.43%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lancer Container Lines Ltd
All →Lancer Container Lines Board Meeting Date
Lancer Container Lines will hold its Board meeting on November 6, 2026, to approve Q2 and H1 FY27 results. No decision has been taken yet.
Lancer Container Lines Other Announcement
Lancer Container Lines Ltd has received approval from the National Stock Exchange (NSE) to list and trade its equity shares on the NSE Main Board effective October 14, 2026.
Lancer Container Lines Management Change
Lancer Container Lines Limited has announced the re-appointment of Mr. Sumit Sadh as the Executive Director of the company.
Lancer Container Lines Annual General Meeting
Lancer Container Lines held its 15th Annual General Meeting on September 29, 2026. The meeting covered adoption of financial statements and routine business resolutions.
Lancer Container Lines ED Probe / Tax Survey
Lancer Container Lines reported a cyber fraud incident involving impersonation, resulting in unauthorized fund transfers totaling ₹0.53 Crore. The company has filed an FIR.
- Value
- ₹0.53 Cr
Lancer Container Lines Annual General Meeting
Lancer Container Lines Ltd. has issued the notice for its 15th Annual General Meeting, scheduled for September 29, 2026, alongside the Annual Report for 2025-26.
Other board meeting date announcements
All →Ultracab (India) Board Meeting Date
Ultracab (India) Ltd intimated that its Board meeting is scheduled for 04-Nov-2026 to consider unaudited standalone financial results. No results or financial figures are disclosed in this advance notice.
Texmaco Infrastructure & Holdings Board Meeting Date
Texmaco has scheduled a Board meeting on November 5, 2026, to approve Q2 and H2 FY27 financial results. Trading window stays closed for insiders pending results declaration.
Astonea Labs Board Meeting Date
Astonea Labs intimated that its Board is scheduled on 14 Nov 2026 to consider unaudited half-year results. The trading window remains closed until 48 hours post-announcement.
AstraZeneca Pharma India Board Meeting Date
AstraZeneca Pharma India scheduled its board meeting for 5 Nov 2026 to approve Q2/H1 FY27 results. The trading window remains closed until 7 Nov 2026.
Mafatlal Industries Board Meeting Date
Mafatlal Industries updated that its 4 November 2026 board meeting will consider an interim dividend for FY27. Record date, if approved, is 13 November 2026.
Inventurus Knowledge Solutions Board Meeting Date
Inventurus Knowledge Solutions will hold a board meeting on 05 November 2026 to consider September 2026 results. This advance notice reports no approved results yet.